Literature DB >> 10397615

Relationship between etomidate plasma concentration and EEG effect in the rat.

P De Paepe1, G Van Hoey, F M Belpaire, M T Rosseel, P A Boon, W A Buylaert.   

Abstract

PURPOSE: The effect-plasma concentration relationship of etomidate was studied in the rat using electroencephalographic changes as a pharmacodynamic parameter.
METHODS: Etomidate was infused (50 mg/kg/h) in chronically instrumented rats (n=6) until isoelectric periods of 5 s or longer were observed in the electroencephalogram (EEG). The EEG was continuously recorded during the experiment and frequent arterial blood samples were taken for determination of etomidate plasma concentrations. The changes observed in the raw EEG signal were quantified using aperiodic analysis in the 2.5-7.5 Hz frequency band. The return of the righting reflex was used as another parameter of anesthesia.
RESULTS: A mean dose of 8.58+/-0.41 mg/kg needed to be infused to reach the end point of 5 s isoelectric EEG. The plasma concentration time profiles were most adequately fitted using a three-exponential model. Systemic clearance, volume of distribution at steady-state and elimination half-life averaged 93+/-6 ml/min/kg, 4.03+/-0.24 l/kg and 59.4+/-10.7 min respectively. The EEG effect-plasma concentration relationship was biphasic exhibiting profound hysteresis. Semi-parametric minimization of this hysteresis revealed an equilibration half-life of 2.65+/-0.15 min, and the biphasic effect-concentration relationship was characterized nonparametrically by descriptors. The effect-site concentration at the return of the righting reflex was 0.44+/-0.03 microg/ml.
CONCLUSIONS: The results of the present study show that the concentration-effect relationship of etomidate can be characterized in individual rats using aperiodic analysis in the 2.5-7.5 Hz frequency band of the EEG. This characterization can be very useful for studying the influence of diseases on the pharmacodynamics of etomidate in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397615     DOI: 10.1023/a:1018894523734

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis.

Authors:  J W Mandema; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  Etomidate: a clinical and electroencephalographic comparison with thiopental.

Authors:  M M Ghoneim; T Yamada
Journal:  Anesth Analg       Date:  1977 Jul-Aug       Impact factor: 5.108

3.  Rectal, oral and I.A. administration of etomidate to rats: significant avoidance of hepatic first-pass elimination following rectal administration.

Authors:  A G de Boer; D D Breimer
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-08

4.  Pharmacodynamic characterization of the electroencephalographic effects of thiopental in rats.

Authors:  W F Ebling; M Danhof; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

5.  Pentobarbital pharmacokinetics in the normal and in the hepatectomized rat.

Authors:  F W Ossenberg; M Peignoux; D Bourdiau; J P Benhamou
Journal:  J Pharmacol Exp Ther       Date:  1975-07       Impact factor: 4.030

6.  Intravenous pharmacokinetic profile in rats of etomidate, a short-acting hypnotic drug.

Authors:  P J Lewi; J J Heykants; P A Janssen
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-03

7.  Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats.

Authors:  S Dutta; W F Ebling
Journal:  J Pharm Pharmacol       Date:  1998-01       Impact factor: 3.765

8.  Plasma concentration and E.E.G. after various regimens of etomidate.

Authors:  A Doenicke; B Löffler; J Kugler; H Suttmann; B Grote
Journal:  Br J Anaesth       Date:  1982-04       Impact factor: 9.166

9.  Increased sensitivity to etomidate in the elderly: initial distribution versus altered brain response.

Authors:  J R Arden; F O Holley; D R Stanski
Journal:  Anesthesiology       Date:  1986-07       Impact factor: 7.892

10.  Electroencephalographic study of the short-acting hypnotics etomidate and methohexital in dogs.

Authors:  A Wauquier; W A van den Broeck; J L Verheyen; P A Janssen
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

View more
  5 in total

1.  Cortico-centric effects of general anesthetics on cerebrocortical evoked potentials.

Authors:  Logan J Voss; James W Sleigh
Journal:  Neurosci Bull       Date:  2015-12       Impact factor: 5.203

2.  A Novel Strategy to Reverse General Anesthesia by Scavenging with the Acyclic Cucurbit[n]uril-type Molecular Container Calabadion 2.

Authors:  Daniel Diaz-Gil; Friederike Haerter; Shane Falcinelli; Shweta Ganapati; Gaya K Hettiarachchi; Jeroen C P Simons; Ben Zhang; Stephanie D Grabitz; Ingrid Moreno Duarte; Joseph F Cotten; Katharina Eikermann-Haerter; Hao Deng; Nancy L Chamberlin; Lyle Isaacs; Volker Briken; Matthias Eikermann
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

3.  The general anesthetic propofol induces ictal-like seizure activity in hippocampal mouse brain slices.

Authors:  Logan J Voss; Liisa Andersson; Anna Jadelind
Journal:  Springerplus       Date:  2015-12-24

4.  Inhibition of astrocyte metabolism is not the primary mechanism for anaesthetic hypnosis.

Authors:  Logan J Voss; Martyn G Harvey; James W Sleigh
Journal:  Springerplus       Date:  2016-07-11

5.  The effect of general anaesthetics on brain lactate release.

Authors:  Anna Hadjihambi; Anastassios Karagiannis; Shefeeq M Theparambil; Gareth L Ackland; Alexander V Gourine
Journal:  Eur J Pharmacol       Date:  2020-05-19       Impact factor: 5.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.